TELA Stock Analysis: Buy, Sell, or Hold?
TELA - TELA Bio, Inc. Common Stock
$0.99
0.03 (3.13%)
▲
5d:
-10.0%
30d:
+51.15%
90d:
+25.99%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When TELA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TELA is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TELA is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TELA is currently trading at $0.99, which is considered extended relative to its 30-day fair value range of $0.61 to $0.98.
Technical Outlook: Technically, TELA is in a downtrend. Immediate support is located at $0.82, while resistance sits at $1.27. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: TELA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.25 (+127.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELA is in a downtrend. Immediate support is located at $0.82, while resistance sits at $1.27. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: TELA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.25 (+127.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.61 -
$0.98
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 127.3% below Wall St target ($2.25)
- WARNING: Recommendation downgraded due to -10.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.61 -
$0.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.82
Resistance Level
$1.27
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.76
Wall Street Target
$2.25
(+127.3%)
Revenue Growth (YoY)
2.9%
Profit Margin
-49.3%
Share & Embed Analysis
Last updated: May 14, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ew Healthcare Partners F…
BUY
3604000 shares
2025-11-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
